Clinical Trial Update: Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma [Phase 2]

View source ↗

Summary

Arrowhead Pharmaceuticals is conducting a Phase 2 trial evaluating inhaled ARO-RAGE for allergen-induced mild asthma, and the study is currently recruiting. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ARO-RAGE (RAGE antagonist (inhaled))

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: RECRUITING